Laurion Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Laurion Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-195,663	Closed	-$21M	–	716
2023 Q1	$21M	Sell	195,663 -235	-0.1%	-$27K	0.14%	137
2022 Q4	$21.5M	Sell	195,898 -31,610	-14%	-$2.05M	0.1%	167
2022 Q3	$13.4M	Sell	227,508 -659	-0.3%	-$30.2K	0.08%	168
2022 Q2	$6.44M	Sell	228,167 -100,000	-30%	-$2.9M	0.1%	140
2022 Q1	$12.4M	Hold	328,167	–	–	0.15%	96
2021 Q4	$13M	Buy	328,167 +159,369	+94%	+$4.99M	0.13%	106
2021 Q3	$4M	Buy	168,798 +106,714	+172%	+$2.52M	0.02%	371
2021 Q2	$1.52M	Buy	62,084 +12,084	+24%	+$270K	0.01%	391
2021 Q1	$913K	Buy	+50,000	New	+$1.03M	﹤0.01%	514

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Laurion Capital Management's RXDX Position: Q2 2023 in Review

Laurion Capital Management sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 195,663 shares — an estimated $21M sold.

Laurion Capital Management first reported a position in RXDX in Q1 2021 and held it in 9 quarters. The position peaked at $21.5M in Q4 2022. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

Laurion Capital Management reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Laurion Capital Management sold 195,663 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $21M.
Laurion Capital Management first reported a position in Prometheus Biosciences, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Laurion Capital Management's Prometheus Biosciences, Inc. Common Stock position peaked at $21.5M in Q4 2022.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.